Skip to content

Pre-dinner vs. Post-dinner Exercise on Glycemic Control

Exercise Timing and Postprandial Glycemia in Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02180620
Enrollment
13
Registered
2014-07-02
Start date
2013-09-30
Completion date
2014-04-30
Last updated
2017-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

GIP, GLP-1, exercise timing, resistance exercise, glucose concentrations

Brief summary

With many medications we prescribe them relative to time of day or a meal. This study established if pre dinner vs post dinner exercise was more effective at altering post dinner glucose and triglyceride levels vs no exercise at all.

Detailed description

All participants completed three trials in a random order in which they consumed a standardized dinner meal with 1) no RE (NoRE), 2) pre-dinner RE (RE→M), and 3) post-dinner RE beginning 45 min after dinner (M→RE). Diet was standardized during the day of testing. Participants reported to the lab for testing sometime between 3 - 5:30 p.m. and upon arrival a venous catheter was inserted into a forearm vein. Frequent blood sampling, indirect calorimetry measurements, and subjective well-being measurements ensued for \ 5.75 h while the participants were in the lab.

Interventions

OTHERNo exercise

During the no exercise trial (NoEX), the participants will remain sedentary during testing.

OTHERMeal then exercise

During the post-meal exercise trial (M→EX), 45 min of resistance training will be performed

OTHERexercise then meal

During the exercise prior to the meal trial (EX→M), 45 min of resistance training will be performed

Sponsors

University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Obese ( body mass index 30-45 kg/m2) * Physician diagnosed with type 2 diabetes receiving standard medical care * Non-smokers * Pregnancy * Lactating mothers

Exclusion criteria

* Insulin * Surgical weight loss * Orthopedic limitations to exercise * Weight loss in the previous 3 months

Design outcomes

Primary

MeasureTime frame
glucose concentrationsBlood samples were taken every 5-10 min during the first 3.7 h of testing and every 30 min during the last 2 h

Secondary

MeasureTime frame
triglyceride concentrationsBlood samples were taken every 5-10 min during the first 3.7 h of testing and every 30 min during the last 2 h

Other

MeasureTime frame
GLP-1 concentrationsBlood samples were taken every 5-10 min during the first 3.7 h of testing and every 30 min during the last 2 h

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026